I maintain that 'founder-led' companies make up a fascinating little cohort of the ASX and here are two great examples, in very different businesses, that appear to be good buying at current prices.
Tungsten is one of the most crucial of all of the critical minerals groups but doesn't get much press. Tungsten also plays a growing role in military technologies, AI and the mooted energy transition. The high-tech defence demand for tungsten is really burgeoning. Here's a look at the Australian-listed producers.
Here are three stocks among the 'mid-cap' stocks that appear to offer good entry points.
This week I’m looking at two minnow food producers on the ASX that both have quite impressive export stories. Here are two minnow food producers […]
Australia hosts a big component of the ancillary industries that service mining. ALS Limited is the big one but two companies are emerging on the global scene, with world-class technology developed in Australia.
This week, I'm looking at the rest of the ASX-listed cardiac health cohort – all of which have different angles in heart health.
Here are three companies in the thriving (though small) sector of the ASX biotech world that are working to get to the heart of cardiac health. All three have unique approaches to it.
Here are three stocks, two with world-leading proprietary software and one with a growing specialisation in providing its clients with the capability and capacity to make AI viable for them. Each one looks to have substantial scope to rise from current prices.
Here are five companies that brought out strong reports for the March 2026 quarter; all of which appear to offer good value at current prices.
Here are two companies tied into waste and recycling that look to be good value at current prices.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.